Keyphrases
Pancreatic Cancer Cells
62%
MTOR Inhibitor
50%
Farnesylthiosalicylic Acid
50%
Effective Treatment
50%
XPO1 Inhibitor
50%
Endoplasmic Reticulum-associated Degradation
50%
Selective Identification
50%
MTOR Pathway
50%
Chemotherapy Resistance
50%
Chemosensitivity
50%
Simultaneous Targeting
50%
Treatment Strategy
50%
B-cell Lymphoma 2 (Bcl-2)
50%
Double-hit Lymphoma
50%
XPO1
50%
Persisters
50%
Synergize
50%
Driver Oncogene
40%
Mammalian Target of Rapamycin (mTOR)
37%
Bcl-2 Inhibitor
30%
Cancer Cells
25%
Library Screen
25%
Oncogene
20%
Pancreatic Ductal Adenocarcinoma
18%
Combined Treatment
14%
Unfolded Protein Response
13%
Autophagy
12%
Non-genetic Mechanisms
12%
Senescence Phenotype
12%
Tumor Expansion
12%
Knockout Library
12%
Drug Treatment
12%
Small Molecules
12%
Tumor Cells
12%
CRISPR Knockout
12%
Chemical Library
12%
Tissue Origin
12%
Drug Tolerant
12%
Senescent Cells
12%
Human Cancer
12%
Paradoxical Role
12%
Small Populations
12%
G2-M Cell Cycle Arrest
12%
Chemotherapy
12%
Cell Surface Display
12%
Chemoresistance
12%
Senescence
12%
Chemotherapy Response
12%
Per Se
12%
In Cancer
12%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
94%
Proteome
50%
Cadherin
50%
Endoplasmic-Reticulum-Associated Protein Degradation
50%
Mammalian Target of Rapamycin
50%
Chemosensitivity
50%
IKK2
50%
Cyclooxygenase
50%
Thiosalicylic Acid
50%
XPO1
50%
Messenger RNA
40%
Genetics
35%
Oncogene
33%
Mouse Model
30%
Carboxylesterase 2
30%
Oncogene C Myc
25%
DNA Damage
25%
Pancreatic Elastase
25%
Immunocompetent Cell
25%
Cell Infiltration
25%
Promoter Region
25%
Phosphotransferase
25%
Kinase
25%
RNA Sequence
20%
Overall Survival
20%
Vimentin
20%
Tumor Progression
15%
CRISPR
15%
Mass Spectrometry
14%
Carcinogenesis
14%
Unfolded Protein Response
13%
Programmed Cell Death
10%
RNA Sequencing
10%
Mesenchymal-Epithelial Transition
10%
Insulin
10%
Wnt Signaling Pathway
10%
Hematopoietic Cell
10%
Immunoblotting
10%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Small Interfering RNA
10%
Transfer RNA
7%
Transgene
7%
Amino Acid
7%
Biomarker Discovery
7%
Biomarker Study
7%
Methionine
7%
Drug Therapy
6%
Small Molecule
6%
Autophagy
6%
Genetic Mechanism
6%
Medicine and Dentistry
Pancreas Cancer
100%
Pancreas Adenocarcinoma
50%
Cancer Therapy
50%
Ras Signaling
50%
Oncogene
50%
Nuclear Export
50%
Chronic Inflammation
50%
Uvomorulin
41%
Malignant Neoplasm
37%
Receptor
33%
Cancer
33%
Messenger RNA
33%
Pancreatic Ductal Adenocarcinoma
27%
Carboxylesterase
25%
Homeostasis
25%
Clinical Trial
25%
Tumor Progression
16%
Pancreatic Cancer Cell Line
16%
Overall Survival
16%
Tumor Cell
16%
Vimentin
16%
RNA Sequence
16%
The Cancer Genome Atlas
16%
Immunohistochemistry
14%
IKK2
12%
Adenocarcinoma
12%
Cyclooxygenase 2
12%
Patient Population
8%
Primary Tumor
8%
Lymphoma Cell
8%
Cell Culture
8%
Brain Metastasis
8%
Programmed Cell Death
8%
Small Interfering RNA
8%
Hematopoietic Cell
8%
Wnt Signaling
8%
Mesenchymal-Epithelial Transition
8%
Clinical Significance
8%
Insulin
8%
Immunoblotting
8%
RNA Sequencing
8%
Cancer Cell Line
8%
Protein Expression
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
P Cadherin
8%
Acinic Cell Carcinoma
6%
Sarcomatoid Carcinoma
6%
Acinar Cell
6%
Oncogene C Myc
6%
Phosphotransferase
6%
